PMDIY (Pro Medicus) Moat Score: 5/10 (As of Jun. 29, 2026)


PMDIY Pro Medicus Ltd PMDIY
77 GF Score
Price $24.45
GF Value $31.72
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pro Medicus Moat Score?

Pro Medicus PMDIY 77 Moat Score is 5 as of Jun. 29, 2026. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $31.72 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 678 Healthcare Providers & Services companies, Pro Medicus ranks better than 96.02% on this metric.

Pro Medicus has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Pro Medicus has Narrow Moat: Pro Medicus Ltd has a solid narrow moat due to its valuable intellectual property in medical imaging software and strong customer loyalty. The company benefits from switching costs in its niche market, but lacks the scale or regulatory barriers to be considered a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Pro Medicus might have Narrow Moat - Solid narrow moat.

Pro Medicus  (OTCPK:PMDIY) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Pro Medicus Moat Score Related Terms

PMDIY vs VEEV, BTSG, TEM: Moat Score Comparison

For the Health Information Services subindustry, Pro Medicus's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pro Medicus Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Moat Score distribution charts can be found below:

* The bar in red indicates where Pro Medicus's Moat Score falls into.


PMDIY
77GF Score
Pro Medicus Ltd PMDIY
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Pro Medicus (PMDIY) has a Moat Score of 5 as of Jun. 29, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Pro Medicus ranks #27 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Pro Medicus' Moat Score too high?
Pro Medicus' current Moat Score is 5. Based on the distribution chart, Pro Medicus ranks #27 out of 678 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Moat Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #27 out of 678 companies for Moat Score. This places Pro Medicus in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Pro Medicus's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.72, compared to a current price of $24.45 — trading 22.9% below its estimated fair value. The current Moat Score is 5. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current Moat Score is 5 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pro Medicus (PMDIY) Overvalued in 2026?

Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued. The current stock price of $24.45 is trading 22.9% below its estimated GF Value™ of $31.72. GuruFocus considers Pro Medicus to be Modestly Undervalued.

Key valuation signals for PMDIY:

  • Moat Score: 5
  • GF Value™: $31.72 vs. price of $24.45 (22.9% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pro Medicus Business Description

Address 450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score

Get the complete analysis for PMDIY

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.45
Price
$31.72
GF Value